Literature DB >> 18349189

Comparative pharmacodynamic modeling using bispectral and narcotrend-index with and without a pharmacodynamic plateau during sevoflurane anesthesia.

Sascha Kreuer1, Jörgen Bruhn, Elisabeth Walter, Reinhard Larsen, Christian C Apfel, Ulrich Grundmann, Andreas Biedler, Wolfram Wilhelm.   

Abstract

BACKGROUND: We compared two pharmacodynamic models, one with and one without a plateau effect. Bispectral indices (BIS, Aspect Medical Systems, Natick, MA, version XP) and Narcotrend (NCT, MonitorTechnik, Bad Bramstedt, Germany, version 4.0) were used as an electroencephalographic measure of sevoflurane drug effect. In addition, we tried to analyze the origin of the plateau.
METHODS: We investigated 26 adult patients scheduled for radical prostatectomy. At least 45 min after induction of general anesthesia, end-tidal sevoflurane concentrations were varied between 1 vol% and 4 vol%. To evaluate the relationship between concentrations and electroencephalographic indices, two different pharmacodynamic models were applied: a conventional model based on a single sigmoidal curve, and a novel model based on two sigmoidal curves for BIS and NCT values with and without burst suppression. The parameters of the models were estimated by NONMEM V (GloboMax, Hanover) by minimizing log likelihood. Statistical significance between the two models was calculated by the likelihood ratio test.
RESULTS: The end-tidal sevoflurane concentration ranged from 1.04 +/- 0.17 vol% to 4.43 +/- 0.43 vol%. The difference between the log likelihood values of the new pharmacokinetic/pharmacodynamic model with two connected sigmoidal curves and the classical E(max) model with one sigmoidal curve is 396 (P < 0.001) for the BIS monitor and 1121 (P < 0.001) for the NCT. The plateau is positioned at the change between the maximum delta power and the increase of burst suppression ratio.
CONCLUSION: A pharmacokinetic/pharmacodynamic model consisting of two sigmoid curves with an intervening plateau describes the effect of sevoflurane on BIS and NCT indices better than a model with a single sigmoid curve.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18349189     DOI: 10.1213/ane.0b013e3181684227

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

1.  Comparative pharmacodynamic modeling of desflurane, sevoflurane and isoflurane.

Authors:  Sascha Kreuer; Jörgen Bruhn; Wolfram Wilhelm; Ulrich Grundmann; Hauke Rensing; Stefan Ziegeler
Journal:  J Clin Monit Comput       Date:  2009-08-27       Impact factor: 2.502

2.  Relationship between bispectral index values and volatile anesthetic concentrations during the maintenance phase of anesthesia in the B-Unaware trial.

Authors:  Elizabeth L Whitlock; Alexander J Villafranca; Nan Lin; Ben J Palanca; Eric Jacobsohn; Kevin J Finkel; Lini Zhang; Beth A Burnside; Heiko A Kaiser; Alex S Evers; Michael S Avidan
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

3.  Comparison between cerebral state index and bispectral index as measures of electroencephalographic effects of sevoflurane using combined sigmoidal E(max) model.

Authors:  Dong Woo Han; Olinto-Jose Linares-Perdomo; Jong Seok Lee; Jun Ho Kim; Steven E Kern
Journal:  Acta Pharmacol Sin       Date:  2011-09-05       Impact factor: 6.150

4.  Failure of two commercial indexes and spectral parameters to reflect the pharmacodynamic effect of desflurane on EEG.

Authors:  Sascha Kreuer; Jörgen Bruhn; Richard Ellerkmann; Stephan Ziegeler; Darius Kubulus; Wolfram Wilhelm
Journal:  J Clin Monit Comput       Date:  2008-03-27       Impact factor: 2.502

5.  Relationship between Sevoflurane Plasma Concentration, Clinical Variables and Bispectral Index Values during Cardiopulmonary Bypass.

Authors:  Rainer Nitzschke; Joana Wilgusch; Jan Felix Kersten; Matthias Sebastian Goepfert
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

6.  Correlation of Sedline-generated variables and clinical signs with anaesthetic depth in experimental pigs receiving propofol.

Authors:  Alessandro Mirra; Claudia Spadavecchia; Olivier Levionnois
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.